The medication binds to GLP-1 receptors in the pancreas to release insulin from the beta cells of the pancreas and to suppress glucagon secretion from the alpha cells
Combining maintenance therapy with regular strength training (which preserves lean muscle and metabolic rate) and consistent protein intake creates a durable foundation for long-term weight stability
A U-100 insulin syringe works for both reconstitution and dosing
Other GLP-1 Receptor Agonists Dulaglutide: A GLP-1 receptor agonist like semaglutide for blood sugar control and weight management can be a good option for some patients
Before taking Pepto-Bismol with Wegovy, you should: Consult your GP or prescribing clinician, particularly if symptoms are severe or persistent Check for contraindications to bismuth subsalicylate (such as aspirin/salicylate allergy, bleeding disorders, kidney problems, pregnancy, breastfeeding, or if under 16 years of age) Consider whether your symptoms might be better managed through Wegovy dose adjustment Avoid prolonged use of Pepto-Bismol without medical advice Be aware that bismuth can cause harmless darkening of stools and tongue, which should not be confused with bleeding If gastrointestinal symptoms are significantly impacting your quality of life, contact your healthcare provider rather than relying solely on over-the-counter remedies
Drawing a full syringe from a 5 mg/mL vial would be a serious dosing error for anyone following standard protocols
